Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study

Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study

Neovascular age-related macular degeneration (nAMD) leads to visual impairment if not treated promptly. Intravitreal anti-VEGF drugs have revolutionized nAMD treatment in the past two decades. We evaluated the visual outcomes of anti-VEGF treatment in nAMD. A real-life population-based cohort study....

Full description

Bibliographic Details
Main Authors: Ida Korva-Gurung, Anna-Maria Kubin, Pasi Ohtonen, Nina Hautala
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Pharmaceuticals
Subjects:
neovascular age-related macular degeneration
visual outcomes
anti-VEGF
visual impairment
population-based cohort
Online Access:https://www.mdpi.com/1424-8247/16/7/927

Internet

https://www.mdpi.com/1424-8247/16/7/927

Similar Items